THE AUTHORS RESPOND
- PMID: 34337997
- PMCID: PMC10391291
- DOI: 10.18553/jmcp.2021.27.8.1141
THE AUTHORS RESPOND
Comment on
-
A RESPONSE TO: "COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES".J Manag Care Spec Pharm. 2021 Aug;27(8):1140-1141. doi: 10.18553/jmcp.2021.27.8.1140. J Manag Care Spec Pharm. 2021. PMID: 34337999 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
